
View larger version (20K):
[in a new window]
|
Fig. 4. Two models of neural induction. Models based on studies in (A)
Xenopus and (B) chick, proposed to reconcile findings on the roles of
BMP, FGF and Wnt signalling in neural induction. (A) In this model, at the
late blastula/early gastrula stage, FGF signalling cooperates with BMP
inhibition to induce a neural (blue) fate by inhibiting Smad1 phosphorylation,
repressing Bmp transcription, and inducing expression of the BMP
antagonists Chordin (Chd) and Noggin (Nog). At low levels,
FGF seems to induce a neural fate directly. High BMP activity induces
epidermis (yellow), while high FGF signalling cooperating with Nodal-related
factors (XNRs) induces mesoderm (red). At earlier (pre-blastula) stages,
Fgf, Xnrs, Bmp, Chd and Nog distribution are determined by
both the nuclear localisation of ß-catenin (orange dots) and the vegetal
localisation of the T-box transcription factor VegT (purple dots), which
pattern the early embryo. Modified, with permission, from Delaune et al.
(Delaune et al., 2005 ). (B) An
alternative but similar model (Wilson and
Edlund, 2001 ) from explant experiments in chick. At the blastula
stage, medial epiblast cells (prospective neural cell) express FGFs but not
Wnts. FGF signalling activates two transduction pathways in epiblast cells:
repression of BMP expression and the promotion of neural fate by an
independent pathway (broken line from FGF). Lateral epiblast cells
(prospective epidermal cell) express both FGFs and Wnts. High Wnt levels block
the response of epiblast cells to FGFs, BMPs are expressed, and BMP signals
promote epidermal fate and repress neural fate. When Wnt signalling is
attenuated, Wnts block the ability of FGFs to repress BMP expression, but the
independent pathway (broken line) promoting neural fate is preserved. Under
these conditions, BMP antagonists are able to induce neural fate. Modified,
with permission, from Wilson and Edlund
(Wilson and Edlund,
2001 ).
|